Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 188
8
Diseases
18
Unique genes
0.267
Avg. similarity score
Stress urinary incontinence
Most-connected disease (5 links)
Disease
Searched: congenital heart defects, multiple types, 2
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
congenital heart defects, multiple types, 2
Stress urinary incontinence
Bicuspid aortic valve
Cardiac anomalies-short stature-joint hypermobility-facial dysmorphism syndrome due to tab2 mutation
Chromosome 6q24-q25 deletion syndrome
Ritscher-schinzler syndrome
hereditary spastic paraplegia 8
aortic valve disease 3
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Stress urinary incontinence | 5 | 5 | 2 |
| Bicuspid aortic valve | 4 | 4 | 14 |
| Cardiac anomalies-short stature-joint hypermobility-facial dysmorphism syndrome due to tab2 mutation | 4 | 4 | 1 |
| Chromosome 6q24-q25 deletion syndrome | 4 | 4 | 1 |
| congenital heart defects, multiple types, 2 | 4 | 4 | 1 |
| Ritscher-schinzler syndrome | 2 | 2 | 4 |
| hereditary spastic paraplegia 8 | 2 | 2 | 1 |
| aortic valve disease 3 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TAB2 | 5 / 8 | Bicuspid aortic valve, Cardiac anomalies-short stature-joint hypermobility-facial dysmorphism syndrome due to tab2 mutation, Chromosome 6q24-q25 deletion syndrome, congenital heart defects, multiple types, 2 and 1 more |
| WASHC5 | 3 / 8 | hereditary spastic paraplegia 8, Ritscher-schinzler syndrome, Stress urinary incontinence |
| ROBO4 | 2 / 8 | aortic valve disease 3, Bicuspid aortic valve |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Apoptotic cleavage of cell adhesion proteins | Reactome | 2 / 11 | 121× | 1.16e-4 | 2.60e-3 ✓ sig. |
| Formation of ATP by chemiosmotic coupling | Reactome | 2 / 18 | 74.1× | 3.20e-4 | 5.81e-3 ✓ sig. |
| Cristae formation | Reactome | 2 / 18 | 74.1× | 3.20e-4 | 5.81e-3 ✓ sig. |
| Defective SLC2A10 causes arterial tortuosity syndrome (ATS) | Reactome | 1 / 1 | 667× | 1.50e-3 | 1.92e-2 ✓ sig. |
| Defective LFNG causes SCDO3 | Reactome | 1 / 5 | 133× | 7.47e-3 | 5.89e-2 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | Reactome | 1 / 5 | 133× | 7.47e-3 | 5.89e-2 |
| Prion disease | KEGG | 3 / 275 | 7.3× | 7.51e-3 | 5.90e-2 |
| Pre-NOTCH Processing in Golgi | Reactome | 1 / 6 | 111× | 8.96e-3 | 6.62e-2 |
| RUNX2 regulates bone development | Reactome | 1 / 7 | 95.3× | 1.04e-2 | 7.29e-2 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | Reactome | 1 / 7 | 95.3× | 1.04e-2 | 7.29e-2 |
| IRAK2 mediated activation of TAK1 complex | Reactome | 1 / 10 | 66.7× | 1.49e-2 | 9.00e-2 |
| Activated NOTCH1 Transmits Signal to the Nucleus | Reactome | 1 / 10 | 66.7× | 1.49e-2 | 9.00e-2 |
| Formation of the cornified envelope | Reactome | 2 / 130 | 10.3× | 1.59e-2 | 9.38e-2 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | Reactome | 1 / 11 | 60.7× | 1.64e-2 | 9.53e-2 |
| Alpha-protein kinase 1 signaling pathway | Reactome | 1 / 11 | 60.7× | 1.64e-2 | 9.53e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| aortic valve morphogenesis | GO:0003180 | 4 / 37 | 112× | 3.90e-8 | 5.53e-6 ✓ sig. |
| atrioventricular node development | GO:0003162 | 2 / 6 | 346× | 1.31e-5 | 6.67e-4 ✓ sig. |
| cardiac ventricle morphogenesis | GO:0003208 | 2 / 10 | 208× | 3.93e-5 | 1.55e-3 ✓ sig. |
| cardiac muscle tissue morphogenesis | GO:0055008 | 2 / 13 | 160× | 6.79e-5 | 2.34e-3 ✓ sig. |
| ventricular trabecula myocardium morphogenesis | GO:0003222 | 2 / 15 | 138× | 9.13e-5 | 2.94e-3 ✓ sig. |
| cardiac septum morphogenesis | GO:0060411 | 2 / 16 | 130× | 1.04e-4 | 3.23e-3 ✓ sig. |
| heart development | GO:0007507 | 4 / 273 | 15.2× | 1.16e-4 | 3.48e-3 ✓ sig. |
| pulmonary valve morphogenesis | GO:0003184 | 2 / 18 | 115× | 1.33e-4 | 3.86e-3 ✓ sig. |
| negative regulation of cardiac muscle hypertrophy | GO:0010614 | 2 / 18 | 115× | 1.33e-4 | 3.86e-3 ✓ sig. |
| negative regulation of myotube differentiation | GO:0010832 | 2 / 18 | 115× | 1.33e-4 | 3.86e-3 ✓ sig. |
| proton motive force-driven ATP synthesis | GO:0015986 | 2 / 23 | 90.3× | 2.19e-4 | 5.54e-3 ✓ sig. |
| cardiac muscle tissue development | GO:0048738 | 2 / 24 | 86.5× | 2.39e-4 | 5.91e-3 ✓ sig. |
| cardiac muscle cell development | GO:0055013 | 2 / 25 | 83.1× | 2.59e-4 | 6.27e-3 ✓ sig. |
| ATP biosynthetic process | GO:0006754 | 2 / 26 | 79.9× | 2.81e-4 | 6.63e-3 ✓ sig. |
| negative regulation of ossification | GO:0030279 | 2 / 27 | 76.9× | 3.03e-4 | 7.02e-3 ✓ sig. |